![Robert Allen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 130 515 $ as of 30/05/2026
Robert D.
Allen is currently Chief Scientific Officer at Invivyd, Inc. since 2023.
Formerly, Dr. Allen was Chief Scientific Officer at SmartPharm Therapeutics, Inc. from 2020 to 2023.
Other former positions include Scientific Director at Oregon Translational Research & Development Institute and Senior Vice President-Research & Development at Sorrento Therapeutics, Inc. Education includes a doctorate from The Trustees of Columbia University in The City of New York, graduate studies at Georgia Institute of Technology, and undergraduate studies at Rhodes College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INVIVYD, INC. 0.05% | 17/02/2026 | 114,487 ( 0.05% ) | 130 515 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 11/04/2023 |
| Companies | Position | End |
|---|---|---|
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology Develops gene encoded therapeutics | Chief Tech/Sci/R&D Officer | 31/12/2022 |
Oregon Translational Research & Development Institute
 Oregon Translational Research & Development Institute Oregon Translational Research & Development Institute (OTRADI) is dedicated to transforming scientific research from laboratories into commercial ventures, focusing on biotechnology, health, and life sciences. The private company is based in Portland. It operates the Bioscience Incubator (OBI), providing startups and scientists access to entrepreneurial mentoring, advanced facilities, shared equipment, and event spaces. OTRADI offers programs such as the Biomentoring Initiative, connecting early-stage life science companies with experienced volunteer mentors who provide advisory support on business planning, regulatory issues, funding, and marketing. The OBI Biomembership program supports founders and entrepreneurs with brand visibility, networking opportunities, access to business tools, mentorship, and participation in leadership roundtables. OTRADI hosts events to foster community engagement and showcase innovative resident startups developing technologies like AI-driven medical solutions, diagnostics, therapeutics, and medical devices. Its resource library features webinars and panel discussions on drug development, regulatory strategies, funding, intellectual property, diversity, and business operations for biotech startups. The institute acknowledges indigenous lands and promotes decolonization within the bioscience industry. | Chief Tech/Sci/R&D Officer | - |
| SORRENTO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 7 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhodes College
 Rhodes College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Oregon Translational Research & Development Institute
Oregon Translational Research & Development Institute Oregon Translational Research & Development Institute (OTRADI) is dedicated to transforming scientific research from laboratories into commercial ventures, focusing on biotechnology, health, and life sciences. The private company is based in Portland. It operates the Bioscience Incubator (OBI), providing startups and scientists access to entrepreneurial mentoring, advanced facilities, shared equipment, and event spaces. OTRADI offers programs such as the Biomentoring Initiative, connecting early-stage life science companies with experienced volunteer mentors who provide advisory support on business planning, regulatory issues, funding, and marketing. The OBI Biomembership program supports founders and entrepreneurs with brand visibility, networking opportunities, access to business tools, mentorship, and participation in leadership roundtables. OTRADI hosts events to foster community engagement and showcase innovative resident startups developing technologies like AI-driven medical solutions, diagnostics, therapeutics, and medical devices. Its resource library features webinars and panel discussions on drug development, regulatory strategies, funding, intellectual property, diversity, and business operations for biotech startups. The institute acknowledges indigenous lands and promotes decolonization within the bioscience industry. | |
SmartPharm Therapeutics, Inc.
SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology Develops gene encoded therapeutics | Health Technology |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
